Cocamide DEA vs Permethrin for Head Lice

• Status: Terminated
• Trial end date: 1999-01-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the efficacy and safety of 10% Cocamide DEA and Lyclear creme rinse (permethrin1%) in the eradication of head lice. To assess the ability of each product to kill all viable ova and to assess patient acceptability of the product in use.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Medical Entomology Centre
• Collaborators: PN Lee Statistics and Computing Ltd; Riemann a/s
• Treatments: Permethrin

Criteria

Inclusion Criteria:

• Male and female patients over the age of 4 who are found to have a head lice infection.

• Patients who give written informed consent or, if the patient is under 16 years of age, whose guardian gives written informed consent to participate in the study.

• Available for the duration of study i.e. 15 days.

Exclusion Criteria:

• Patients with a known sensitivity to pyrethroid, organophosphate, and/or carbamate insecticides, sensitivity to chrysanthemums and/or known sensitivity to paraben preservatives.

• Patients who have been treated with other head lice products within the last 4 weeks.

• Patients who have undergone a course of antibiotic treatment within the last 4 weeks.

• Patients who have any persistent skin disorder of the scalp (i.e. eczema, chronic dermatitis, psoriasis).

• Patients with asthma

• Patients whose hair has been bleached, colour treated or permed within the last 4 weeks.

• Pregnant or nursing mothers.

• Patients who have participated in another clinical trial within 1 month prior to entry to this study.

• Patients who have already participated in this clinical trial.